Could many women safely skip breast cancer radiation?
NCT ID NCT02653755
Summary
This study is testing whether some women with early-stage, low-risk breast cancer can safely skip radiation treatment after having a lumpectomy (breast-conserving surgery). Researchers are using a special tumor test called Prosigna to identify patients who have a very low risk of their cancer returning. The goal is to see if these selected patients can avoid the side effects and burden of radiation without increasing their risk of recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER RADIATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Johns Hopkins
Baltimore, Maryland, 21287, United States
-
Lifespan Cancer Institute
Providence, Rhode Island, 02903, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Sloane Kettering Cancer Center
New York, New York, 10065, United States
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.